According to Xencor's latest financial reports and stock price the company's current Operating Margin is -141.63%. At the end of 2021 the company had an Operating Margin of 15.91%.
Year | Operating Margin | Change |
---|---|---|
2021 | 15.91% | -125.42% |
2020 | -62.59% | -809.51% |
2019 | 8.82% | -105.09% |
2018 | -173.37% | 25.39% |
2017 | -138.26% | -591.16% |
2016 | 28.15% | -144.46% |
2015 | -63.32% | -63.27% |
2014 | -172.41% | -70.3% |
2013 | -580.48% | 801.43% |
2012 | -64.40% | -52.84% |
2011 | -136.56% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 22.88% | -116.15% | ๐บ๐ธ USA |
AbbVie ABBV | 18.65% | -113.17% | ๐บ๐ธ USA |
Amgen AMGN | 34.59% | -124.42% | ๐บ๐ธ USA |
Merck MRK | 27.73% | -119.58% | ๐บ๐ธ USA |
Seagen
SGEN | -30.69% | -78.33% | ๐บ๐ธ USA |
MacroGenics MGNX | 0.00% | N/A | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.